Trial Profile
Long-term usage of darbepoetin alpha in non-dialysis CKD patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Mar 2020
Price :
$35
*
At a glance
- Drugs Darbepoetin alfa (Primary)
- Indications Anaemia
- Focus Adverse reactions
- Acronyms DREAM-J
- Sponsors Kyowa Hakko Kirin; Kyowa Kirin
- 03 Aug 2016 Status changed from active, no longer recruiting to completed.
- 27 Apr 2015 New trial record